mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.15 |
0.01 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |